AQR Capital Management LLC cut its stake in Insmed Incorporated (NASDAQ:INSM) by 13.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Insmed (NASDAQ:INSM) was downgraded by equities research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday, BidAskClub reports. Seve
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of Carol A. Schafe
Shares of Insmed Incorporated (NASDAQ:INSM) have been assigned an average recommendation of “Buy” from the eleven research firms that are currently covering the firm, MarketBeat reports. One resea
Great West Life Assurance Co. Can bought a new stake in shares of Insmed Incorporated (NASDAQ:INSM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commissi
Amalgamated Bank boosted its position in shares of Insmed Incorporated (NASDAQ:INSM) by 18.1% during the 4th quarter, HoldingsChannel reports. The firm owned 16,245 shares of the biopharmaceutical com
Dynamic Technology Lab Private Ltd purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM) during the fourth quarter, according to the company in its most recent Form 13F filing with t
Insmed (NASDAQ:INSM) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday, ValuEngine reports. Other equities res
In a report issued on March 17, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Insmed (INSM –
Wall Street brokerages expect Insmed Incorporated (NASDAQ:INSM) to announce earnings of ($0.63) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates
Alyeska Investment Group L.P. lessened its stake in shares of Insmed Incorporated (NASDAQ:INSM) by 46.4% during the fourth quarter, according to the company in its most recent disclosure with the Secu
Insmed Incorporated (NASDAQ:INSM) traded down 7.2% during trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $55.00 to $45.00. Stifel Nicolaus currently has a buy
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE